2016
DOI: 10.1111/ijd.13249
|View full text |Cite
|
Sign up to set email alerts
|

Juvenile hyaline fibromatosis: report of a rare case at an advanced stage with osteosclerosis and scoliosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2016
2016
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 8 publications
0
1
0
1
Order By: Relevance
“…[3] Recent studies have identified Capillary Morphogenesis Protein 2 (CMG2) mutation encoded by a gene on chromosome 4q21 to be the causative factor. [4] We report this case due to the rarity of the disorder and to the best of our knowledge, the first case in literature where JHF presented with subcutaneous nodules as the sole manifestation with no other associated manifestations so far in an adult man. The clinical presentation, genetic basis, histopathological findings, differential diagnosis and treatment options have been discussed and literature reviewed.…”
Section: How To Cite This Articlementioning
confidence: 87%
“…[3] Recent studies have identified Capillary Morphogenesis Protein 2 (CMG2) mutation encoded by a gene on chromosome 4q21 to be the causative factor. [4] We report this case due to the rarity of the disorder and to the best of our knowledge, the first case in literature where JHF presented with subcutaneous nodules as the sole manifestation with no other associated manifestations so far in an adult man. The clinical presentation, genetic basis, histopathological findings, differential diagnosis and treatment options have been discussed and literature reviewed.…”
Section: How To Cite This Articlementioning
confidence: 87%
“…El Cuadro 2 muestra la comparación de los casos clínicos descritos en la bibliografía con síndrome de fibromatosis hialina infantil, incluido el nuestro, con los principales datos clínicos de los pacientes. [21][22][23][24][25][26][27] La movilidad articular en pacientes con síndrome de fibromatosis hialina suele mejorar con la administración de penicilamina, 1,2 antiinflamatorios no esteroides, opiáceos y gabapentina para el tratamiento del dolor, además de fisioterapia. Algunos casos requieren tratamiento paliativo.…”
Section: Discussionunclassified